Researchers at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center propose a simpler, safer procedure for treating a certain type of early-stage kidney cancer in older adults.
A year into Cornell’s Academic Integration Initiative, Gary Koretzky ’78 is relocating to Ithaca and taking on a new title to continue leading efforts to better promote, build and enhance collaborative research efforts across Cornell's campuses.
A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis.
A Western-style diet triggers changes in the brain that may predispose patients to Alzheimer’s disease decades before they show any sign of cognitive decline.
Cornell Tech and Weill Cornell Medicine students teamed up with Roosevelt Island senior citizens to understand technology solutions that could make their lives a little easier.
Dr. Hannah Valantine, chief officer for scientific workforce diversity at the NIH, advocated for diversity in academic medicine at Weill Cornell Medicine.
